AEON Biopharma, Inc. Stock Nasdaq
Equities
AEON
US00775E1029
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.18M | Capitalization | 268M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 228 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.81% |
1st Jan change | Capi. | |
---|---|---|
-2.34% | 103B | |
+2.31% | 96.56B | |
+1.11% | 22.61B | |
-16.72% | 21.18B | |
-3.71% | 19.07B | |
-41.75% | 16.53B | |
-23.26% | 14.46B | |
-0.02% | 13.25B | |
+22.69% | 11.1B |